Safety and Efficacy of Sintilimab and Anlotinib as First Line Treatment for Advanced Hepatocellular Carcinoma (KEEP-G04): A Single-Arm Phase 2 Study https://t.co/pSoPRQ2lkr
38 followers
1,384 followers
Safety and Efficacy of Sintilimab and Anlotinib as First Line Treatment for Advanced Hepatocellular Carcinoma (KEEP-G04): A Single-Arm Phase 2 Study by Xiaofeng Chen https://t.co/rMN1tlgOo2
6,546 followers
New research: Safety and Efficacy of Sintilimab and Anlotinib as First Line Treatment for Advanced Hepatocellular Carcinoma (KEEP-G04): A Single-Arm Phase 2 Study: Purpose Immune checkpoint inhibitors plus antiangiogenic tyrosine kinase… https://t.co/4vJ2